Allegheny Financial Group LTD Mesoblast LTD Transaction History

Allegheny Financial Group LTD

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 09, 2022	BUY	$4.17 - $7.09 $1,296 - $2,204	311 New	311 $1,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Allegheny Financial Group LTD, based on Form 13F filings with the SEC.

Stay updated on Allegheny Financial Group LTD with notifications on news.